NovaBridge Biosciences
NBPBiotechnology
$1.21−3.97%As of Oct 29vs prior close
- Market cap
- $140.4M
- P/E (TTM)
- –
- From 52W high
- −75.56%
- EPS (YE25)
- -$0.21
- Revenue (YE23)
- $632K
- Dividend yield
- 0.00%
Nomior Score
30
Steady ProfileBottom 15% of the scored universe
Growth—
Quality52
Value52
Momentum1
Resilience41
Growth
−38.12%revenue a year over 4 fiscal years
YE19 $4.3MYE23 $632K
Connections
Revenue to profitYE23
The operating loss was 11395% of revenue.
Who owns it
1tracked portfolio